The Gates Foundation Sold All of Its Remaining Microsoft Stock. Should Investors Be Worried?

The Gates Foundation sold its final 7.7 million Microsoft shares, a stake worth about $3.2 billion, as part of a plan to spend its entire endowment by 2045 rather than a bearish view on Microsoft. Microsoft's latest quarter remained strong, with revenue up 18% to $82.9 billion and diluted EPS and net income both rising 23%. The article frames the stock as still attractive for long-term investors despite year-to-date weakness of about 13%.

Analysis

The Gates Foundation liquidation is not a fundamental signal on MSFT; it is a mechanically forced seller with a long runway, which matters more for tape flow than for valuation. The real second-order effect is that one of the most patient large holders is being replaced by a broad base of incremental buyers: index funds, AI crossover funds, and corporate treasuries that want exposure to the AI infrastructure stack without single-commodity risk. That tends to reduce stock-specific overhang over months, but it can also suppress upside if every rally is met by predictable endowment-driven supply.

The more important read-through is competitive positioning in AI capex. MSFT’s earnings power is strong enough to keep funding large-scale infrastructure spend, but the market is still underestimating how much of the next 12-18 months of returns may be driven by margin structure rather than top-line growth. If AI monetization lags capex, MSFT can still look “cheap” on growth while multiple expansion stalls; if utilization and copilot attach rates improve faster than expected, the stock can rerate quickly because investors are currently pricing a durability discount, not a failure of the franchise.

For NFLX and NVDA, the article’s own comparison language is a useful reminder that relative momentum is now doing more work than fundamentals in some parts of tech. NVDA remains the cleaner second-order beneficiary of continued hyperscaler capex, while INTC is still the highest-beta laggard to any AI spend shift and a poor expression of this theme unless you want a turnaround hedge. The contrarian view is that MSFT’s drawdown already reflects the most obvious risks, so forced selling by a philanthropic holder may be a better medium-term entry point than a warning sign; the risk is only if broader enterprise software spend softens, in which case the AI narrative loses its ability to offset slower core growth.

Key Decisions for Investors

• Add to MSFT on weakness over the next 2-6 weeks, with a 6-12 month horizon; risk/reward improves if the stock continues to trade below its recent range while earnings quality stays intact.
• Pair trade: long NVDA / short INTC for a 3-9 month expression of AI capex leadership; this isolates spend migration toward the strongest platform beneficiary and avoids paying for a turnaround that may take years.
• Use MSFT as a defensive long against broader software weakness only if you can tolerate capped near-term upside; consider covered calls 60-90 days out to monetize the likely supply overhang and elevated implied vol.
• If you want a cleaner relative-value expression, long MSFT / short NFLX on a 3-6 month basis; MSFT has a more durable monetization path from AI, while NFLX is more exposed to multiple compression if rates or risk appetite worsen.
• Avoid INTC as a directional long here; only consider it as a small hedge against a surprise broadening of AI spend beyond current leaders, with the understanding that the thesis is low-conviction and catalyst-poor.